Live Breaking News & Updates on Adverum Biotechnologies Inc
Stay updated with breaking news from Adverum biotechnologies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) have earned an average rating of “Buy” from the four brokerages that are covering the stock, Marketbeat reports. Four analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […] ....
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has received an average rating of “Buy” from the four brokerages that are currently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have issued a report on the stock in the […] ....
Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) have been given an average rating of “Buy” by the four analysts that are covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have covered the stock in […] ....
Analysts’ upgrades for Monday, May 27th: Adverum Biotechnologies (NASDAQ:ADVM) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. American Eagle Outfitters (NYSE:AEO) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Air Products and Chemicals (NYSE:APD) was upgraded by analysts at StockNews.com from a sell […] ....
Press release - DelveInsight Business Research - Friedreich s Ataxia Market to Observe Impressive Growth During the Forecast Period (2024-2034), Evaluates DelveInsight | Reata Pharma, Retrotope, PTC Therapeutics, Minoryx Therapeutics - published on openPR.com ....